Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.

Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34285853

about

Combination of gemcitabine-containing magnetoliposome and oxaliplatin-containing magnetoliposome in breast cancer treatment: A possible mechanism with potential for clinical application.

P2860

Q37536696-42DBDE25-44CB-4C37-A924-E55E2D055623

P2860

Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34285853

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@ast

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@en

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@nl

type

label

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@ast

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@en

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@nl

prefLabel

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@ast

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@en

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@nl

P1433

Q34285853-A158059E-0F31-4DDA-955C-554B6FB02A13

P1476

Q34285853-FDEDB1BF-4AE7-4481-9F84-D0AF27DFE271

P2093

Q34285853-04C8EFC6-93DA-47B6-A34F-80E934FD3A73

Q34285853-0F27C732-C8D2-4529-BB85-55C3C3D98C39

Q34285853-3255EF80-D97F-449B-8BF2-4CF625931B52

Q34285853-46FBF236-342D-4B39-9234-C1EE584DF22D

Q34285853-5D9E57AE-5BEC-4167-B59E-0B7E66FC71CF

Q34285853-63CFB4C7-869C-43A5-A1FE-ED4205F17690

Q34285853-7289DB61-3FA8-4099-A22E-E046890C37D5

Q34285853-742F736E-F873-430B-AA0D-08F493D40D82

Q34285853-BE3725C5-020E-463D-B4B5-567A16E71DC3

Q34285853-DA3B5BB6-2BB8-4153-954F-D60AA2751760

P2860

Q34285853-04774FEB-5742-44ED-917E-E8D2850BBB19

Q34285853-069F3E0A-E7E8-4B1A-A147-D5BB8E261C81

Q34285853-0FA2047B-1259-47FB-8CF5-CAAA8904F956

Q34285853-16D914E6-DDEA-4E5F-BC14-A0E026366BF7

Q34285853-1F6E6D7C-00B6-4340-82F3-3621DD18F453

Q34285853-1FC5B311-B32C-481A-9E9A-73F424B3F7EC

Q34285853-25CA6C83-47D5-4263-A733-8ED971B05A03

Q34285853-264A0692-5689-4116-BF49-8206D8649F52

Q34285853-27C427F1-92D4-4E8F-93EB-65A6FBC2FB54

Q34285853-28D4DC87-180F-458E-A43B-6EAF41227F98

P304

Q34285853-09931466-6381-413B-818C-E9044A755F02

P31

Q34285853-006C8E9F-476C-427E-ADB4-0334A7B38B42

P356

Q34285853-D25120ED-85A0-4F77-A18B-5149092E9E1A

P407

Q34285853-82ACE021-1AF7-46BD-A067-BFE5A2C53846

P478

Q34285853-DA9E435D-0132-4E53-9C5C-ECA9F3C058B4

P577

Q34285853-BA973B9D-DF52-471F-93C0-77B05BC83486

P698

Q34285853-9AFC237B-CF6E-4272-816B-1BF496081C02

P932

Q34285853-89E70EAF-E6A7-4C2A-81E7-74BDC9E06F1E

P356

P1433

International Journal of Nanomedicine

P1476

Preclinical evaluation of reco ...... ting hepatocellular carcinoma.

@en

P2093

Botao Tan

http://www.w3.org/2001/XMLSchema#string

Heng Jiang

http://www.w3.org/2001/XMLSchema#string

Hui Ye

http://www.w3.org/2001/XMLSchema#string

Jianguang Wang

http://www.w3.org/2001/XMLSchema#string

Jiansong Tong

http://www.w3.org/2001/XMLSchema#string

Jianzhang Wu

http://www.w3.org/2001/XMLSchema#string

Mengjing Shi

http://www.w3.org/2001/XMLSchema#string

Sha Jin

http://www.w3.org/2001/XMLSchema#string

Shenjie Wu

http://www.w3.org/2001/XMLSchema#string

Weibo Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer

Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.

Caspase inhibitors in prevention of apoptosis.

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.

Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice.

IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis

P304

4533-4550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S67228

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25288882

http://www.w3.org/2001/XMLSchema#string

P932

4184408

http://www.w3.org/2001/XMLSchema#string